Home › Forums › General Discussion › Force degradation studies for MDI Formulation in Brasil
Does anyone have information/rational/experience for conducting forced degradation studies on MDI formulations to meet Brazil RDC53 regulations?
Posted on behalf of Sylvine P. at GSK.
Some of these references may prove helpful. I’ll post your question in the discussion forum to see if other Stabilitarians might comment.
ANVISA’s Guidance on Forced Degradation Studies Explained
ANVISA’s Guidance on Forced Degradation Studies Explained – Part 2
ANVISA’s Guidance on Forced Degradation Studies Explained – Part 3
New developments in the pharmaceutical stress testing industry
Please review StabilityHub’s policies for details about data, information, and site use.
August 23 @ 1:00 pm - August 25 @ 4:30 pm
June 19 - June 23
Copyright ©2023 | STABILITYHUB | ALL RIGHTS RESERVED | BUILT BY CAVETTEK, LLC
If you have not yet signed up for the StabilityHub newsletter, join hundreds of other stabilitarians to get the latest news, publications, job opportunities and more!
Email Address *
First Name *
Last Name *
Job Title *
Example: Yes, I would like to receive emails from StabilityHub. (You can unsubscribe anytime)